Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (51-60 of 230) with videos related to

Pageof 23
Sort By:
Orphanet Journal of Rare Diseases|May 5, 2019
Burden of adult neurofibromatosis 1: development and validation of a burden assessment toolMarie-Laure Armand, Charles Taieb, Aline Bourgeois, et al.
Journal of the American Academy of Dermatology|November 6, 2018
Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristicsGuillaume Chaby, Saskia Ingen-Housz-Oro, Nicolas De Prost, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|October 14, 2014
Treatment of sphenoid dysplasia with a titanium-reinforced porous polyethylene implant in orbitofrontal neurofibroma: report of three casesJeremy Niddam, Romain Bosc, Tabrez M Suffee, et al.
American Journal of Medical Genetics. Part A|November 4, 2004
Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patientsKiarash Khosrotehrani, Sylvie Bastuji-Garin, Vincent M Riccardi, et al.
European Journal of Hospital Pharmacy : Science and Practice|April 17, 2020
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromasGuillaume Le Guyader, Victoire Vieillard, Karine Andrieux, et al.
American Journal of Medical Genetics. Part A|August 15, 2006
Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American casesPatricia Z Page, Grier P Page, Emmanuel Ecosse, et al.
Archives of Dermatology|December 17, 2003
French people and skin diseases: results of a survey using a representative samplePierre Wolkenstein, Jean-Jacques Grob, Sylvie Bastuji-Garin, et al.
American Journal of Medical Genetics. Part A|December 14, 2007
Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patientsDavid Farhi, Sylvie Bastuji-Garin, Kiarash Khosrotehrani, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 29, 2011
Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1Tracy Tucker, Vincent M Riccardi, Margaret Sutcliffe, et al.
Archives of Dermatology|November 23, 2011
A rare cause of acquired telangiectases extending from the feet to armsMarie Ferneiny, Nicolas Ortonne, Saskia Ingen-Housz-Oro, et al.
Pageof 23

Showing results (51-60 of 230) with videos related to

Sort By:
Pageof 23
Orphanet Journal of Rare Diseases|May 5, 2019
Burden of adult neurofibromatosis 1: development and validation of a burden assessment toolMarie-Laure Armand, Charles Taieb, Aline Bourgeois, et al.
Journal of the American Academy of Dermatology|November 6, 2018
Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristicsGuillaume Chaby, Saskia Ingen-Housz-Oro, Nicolas De Prost, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|October 14, 2014
Treatment of sphenoid dysplasia with a titanium-reinforced porous polyethylene implant in orbitofrontal neurofibroma: report of three casesJeremy Niddam, Romain Bosc, Tabrez M Suffee, et al.
American Journal of Medical Genetics. Part A|November 4, 2004
Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patientsKiarash Khosrotehrani, Sylvie Bastuji-Garin, Vincent M Riccardi, et al.
European Journal of Hospital Pharmacy : Science and Practice|April 17, 2020
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromasGuillaume Le Guyader, Victoire Vieillard, Karine Andrieux, et al.
American Journal of Medical Genetics. Part A|August 15, 2006
Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American casesPatricia Z Page, Grier P Page, Emmanuel Ecosse, et al.
Archives of Dermatology|December 17, 2003
French people and skin diseases: results of a survey using a representative samplePierre Wolkenstein, Jean-Jacques Grob, Sylvie Bastuji-Garin, et al.
American Journal of Medical Genetics. Part A|December 14, 2007
Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patientsDavid Farhi, Sylvie Bastuji-Garin, Kiarash Khosrotehrani, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 29, 2011
Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1Tracy Tucker, Vincent M Riccardi, Margaret Sutcliffe, et al.
Archives of Dermatology|November 23, 2011
A rare cause of acquired telangiectases extending from the feet to armsMarie Ferneiny, Nicolas Ortonne, Saskia Ingen-Housz-Oro, et al.
Pageof 23